Somatostatin analogues: reduce gastric emptying, slow intestinal transit, and inhibit the secretion of gastrointestinal hormones, including GLP-1, insulin and postprandial vasodilation
GLP-1 drugs are not the first class of medications to create this tension, and they will not be the last
Ethics declarations Competing interests All authors are current or former employees of 23andMe
This translates into a total growth of 700% , with the market forecast to expand at a compound annual growth rate (CAGR) of 23.1% between 2025 and 2035
The dominant mechanism identified across the medical literature is telogen effluvium , a diffuse, non-scarring shedding condition
The majority of patients across all groups those currently on a GLP-1, thinking of it, or who used to take one said "yes." Among those who used to take a GLP-1, 42% said they gained "some" weight back after stopping treatment